This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cuddihy, A E Articles by Kuehl, W M Search for Related Content PubMed PubMed Citation Articles by Cuddihy, A E Articles by Kuehl, W M

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 June; 13(6): 3505-3513

Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20889.

ABSTRACT

The c-Myb protein is a transcription factor with an apparent but poorly defined role in hematopoietic cell growth and differentiation. The DNA binding and several transcriptional regulatory domains of the c-Myb protein have been defined by transient transfections into nonhematopoietic cell lines. Although the relationship between these domains and transformation has been studied, little is known about the function of these domains during hematopoietic maturation. Up-regulation of stably transfected c-myb in murine erythroleukemia (MEL) cells blocks terminal differentiation when MEL cells are induced to differentiate with N,N'-hexamethylene bisacetamide. To determine which functional domains of c-Myb are necessary and sufficient to block differentiation, mutated c-myb constructs under the control of a murine metallothionein promoter were transfected into C19 MEL cells, and stable clonal cell lines were established. The ability of Myb mutants to block differentiation paralleled their ability to transactivate transcription of a reporter gene containing Myb-responsive elements, by transient transfection into a lymphoid cell line. The smallest c-Myb mutant able to block differentiation consisted of the DNA binding domain juxtaposed to the transactivation domain. Therefore, the DNA binding domain and the transactivation domain are necessary and sufficient for c-Myb to block differentiation in MEL cells.

This article has been cited by other articles:

• Blaydes, S. M., Kogan, S. C., Truong, B.-T. H., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Largaespada, D. A., Brannan, C. I. (2001). Retroviral Integration at the Epi1 Locus Cooperates with Nf1 Gene Loss in the Progression to Acute Myeloid Leukemia. J. Virol. 75: 9427-9434 [Abstract] [Full Text]  
• Matsumura, I., Kawasaki, A., Tanaka, H., Sonoyama, J., Ezoe, S., Minegishi, N., Nakajima, K., Yamamoto, M., Kanakura, Y. (2000). Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines. Blood 96: 2440-2450 [Abstract] [Full Text]  
• Afroze, T., Husain, M. (2000). c-Myb-binding Sites Mediate G1/S-associated Repression of the Plasma Membrane Ca2+-ATPase-1 Promoter. J. Biol. Chem. 275: 9062-9069 [Abstract] [Full Text]  
• Miglarese, M. R., Richardson, A. F., Aziz, N., Bender, T. P. (1996). Differential Regulation of c-Myb-induced Transcription Activation by a Phosphorylation Site in the Negative Regulatory Domain. J. Biol. Chem. 271: 22697-22705 [Abstract] [Full Text]  
• Shapiro, L. H., Shapiro, L. H. (1995). Myb and Ets Proteins Cooperate to Transactivate an Early Myeloid Gene. J. Biol. Chem. 270: 8763-8771 [Abstract] [Full Text]